SEC Form 4 · accession 0001274225-18-000007
MYRIAD GENETICS INC · MYGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dennis Langer
Director
Period of report
May 30, 2018
Accepted (ET)
Jun 1, 2018 · 4:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000899923
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 30, 2018 | M | 10,000 | $24.39 | A | 49,743 | D | |
| Common Stock | May 30, 2018 | S | 10,000 | $37.9245 | D | 39,743 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $24.39 | May 30, 2018 | M | 10,000 | D | May 30, 2018 | Nov 13, 2018 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan.